Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study
Author:
Affiliation:
1. Hope Neurology Multiple Sclerosis Center, Knoxville, TN, USA
2. EMD Serono, Inc., Billerica, MA, USA
3. The MS Center for Innovations in Care, Missouri Baptist Medical Center, St. Louis, MO, USA
Funder
EMD Serono, Inc
Publisher
Informa UK Limited
Subject
Pharmaceutical Science
Link
https://www.tandfonline.com/doi/pdf/10.1080/17425247.2018.1407755
Reference22 articles.
1. Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study
2. Safety and Tolerability in Relapsing-Remitting Multiple Sclerosis Patients Treated With High-Dose Subcutaneous Interferon-Beta by Rebiject Autoinjection Over a 1-Year Period
3. Validation of the Multiple Sclerosis International Quality of Life questionnaire
4. Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design;Advanced Drug Delivery Reviews;2024-06
2. Autoinjector Design Parameters: A Human Factors Perspective;Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care;2023-03
3. Understanding patient preferences for handheld autoinjectors versus wearable large-volume injectors;Expert Opinion on Drug Delivery;2022-12-26
4. Application effect of centralized management combined with Information system application management in recycling, cleaning, disinfection and packaging of radiology instruments and reusable medical devices;Food Science and Technology;2021-09-17
5. Potential Benefits of the Self-Administration of Subcutaneous Methotrexate with Autoinjector Devices for Patients: A Review;Drug, Healthcare and Patient Safety;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3